Skip to main content

Table 2 Overview of \({\text{SNP}}\times {\text{sex}}\) and \({\text{SNP}}\times {\text{statin}}\) interactions significant after hierarchical FDR control

From: Sex and statin-related genetic associations at the PCSK9 gene locus: results of genome-wide association meta-analysis

Cytoband

Candidate gene

SNP

Best subgroup

Type

\(\left|\Delta \right|\)

q-value

1p32.3

PCSK9

rs11591147

Free

Statin-relateda

0.080

8.77 × 10–3

1p32.3

PCSK9

rs693668

M

Sex-relatedb

0.022

2.55 × 10–4

1p32.3

PCSK9

rs11583680

M

Statin-relatedc

0.031

1.56 × 10–2

2p24.1

APOB

rs1367117

Free

Free-specific

0.019

5.98 × 10–3

10q21.3

JMJD1C

rs1074013

Free

Free-specific

0.014

2.73 × 10–2

6q11.1

KHDRBS2

rs3076276

Treated

Treatment-specific

0.072

2.45 × 10–5

7q36.1

PRKAG2

rs34924001

M—free

Male-specific

0.040

1.73 × 10–4

7q36.1

PRKAG2

rs34924001

M—free

Free-specific

0.052

1.73 × 10–4

10q11.21

ALOX5

rs76849715

M—free

Male-specific

0.057

2.79 × 10–4

10q11.21

ALOX5

rs76849715

M—free

Free-specific

0.054

2.97 × 10–3

12p12.2

SLCO1B3

rs4762806

W—free

Female-specific

0.071

1.22 × 10–3

12q24.22

NOS1

rs4767549

M

Male-specific

0.018

2.46 × 10–3

  1. All 14 independent SNPs were tested for 2-way interactions. We first report significant interactions at the PCSK9 locus, then other known loci, and finally, for the novel loci identified in our meta-analysis. We only report the absolute differences of effects as the sign also depends on the choice of effect alleles. The significant interaction was denoted stratum-specific, if the SNP effect was suggestive significant (p < 1 × 10–6) in only one of the two tested subgroups, and stratum-related, if the SNP had suggestively significant effects in both compared subgroups. For complete results, see Additional file 2: Table S6a
  2. aStronger effect in statin-free individuals
  3. bStronger effects in men
  4. cStronger effects in statin-treated individuals